Canada markets open in 5 hours 59 minutes

Eli Lilly and Company (LLY)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
247.07+2.95 (+1.21%)
At close: 04:03PM EST
246.04 -1.03 (-0.42%)
After hours: 07:59PM EST
Full screen
Loading interactive chart...
  • Reuters

    Germany's Evotec partners with Lilly to research metabolic diseases

    German biotech company Evotec said on Tuesday that it had entered into a drug discovery collaboration in metabolic diseases with U.S. drugmaker Eli Lilly. The total potential value of the collaboration, which will run for three years, is up to $1 billion. As part of the collaboration, Evotec will explore potential drug candidates for the treatment of diabetes and chronic liver disease, the Hamburg-based company said.

  • Zacks

    AbbVie's (ABBV) Rinvoq Gets FDA Nod for Atopic Dermatitis

    FDA approves AbbVie's (ABBV) Rinvoq for the treatment of moderate to severe atopic dermatitis in adults and children aged 12 and above. This is the third indication for Rinvoq in the United States.

  • Zacks

    Glaxo (GSK), Vir Seek EUA for Intramuscular Sotrovimab in US

    Glaxo (GSK) and Vir are looking to get authorization for the intramuscular administration of their COVID-19 drug candidate, sotrovimab, which is currently authorized for intravenous administration.